A controversial ER negative PR positive molecular subtype of breast carcinoma-Report of two cases.
Breast Dis
; 42(1): 315-318, 2023.
Article
en En
| MEDLINE
| ID: mdl-37807774
ABSTRACT
ER-/PR+ is a controversial subtype and is not formally recognised as molecular subtype of breast carcinoma. Few studies concluded that this subtype does not exist and is due to technical errors, however, in contrast others consider it to be distinct entity with different response to therapy and clinical outcome. It is also essential to know whether this subtype shows any distinct histomorphological features or prognosis.Therefore, the present two cases of controversial subtype ER-/PR+ breast cancer is being reported with both the cases showing neuroendocrinal differentiation.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias de la Mama
Límite:
Female
/
Humans
Idioma:
En
Revista:
Breast Dis
Asunto de la revista:
GINECOLOGIA
Año:
2023
Tipo del documento:
Article
País de afiliación:
India